(redirected from anaerobic infection)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • adj

Synonyms for anaerobic

living or active in the absence of free oxygen

not aerobic


References in periodicals archive ?
The present case suggests that (1) the recommended oral antibiotic treatment for acute pharyngeal infections does not always prevent the progression of the disease into the life-threatening Lemierre's syndrome; (2) an anaerobic infection and the Lemierre's syndrome should be suspected in patients affected by a pharyngotonsillitis with a severe and unusual course; (3) in these patients an empirical antibiotic therapy, active also against anaerobic microorganism, has to be started early; moreover, an imaging study of the neck, searching for jugular thrombophlebitis and parapharyngeal abscesses, should be obtained as soon as possible.
Other expert witnesses had speculated that the patient died from complications of an anaerobic infection.
Microbiologists who lack a fluorescent microscope nevertheless can--through skillful interpretation of the initial Gram-stained material--alert physicians to a potentially serious anaerobic infection.
15] (1987) report 86% patients had anaerobic infection.
The commonly used antimicrobial for anaerobic infection is Metronidazole.
For example, hospitals in developing countries still routinely obtain and process anaerobic blood cultures, despite that a positive anaerobic blood culture often reflects an underlying anaerobic infection (e.
Abscesses are often polymicrobial in nature involving both aerobic and anaerobic infection.
In addition, thoracic radiography showed only bilateral diffuse pulmonary infiltrates, which was not suggestive of an anaerobic infection.
based on one or more clinical clues suggestive of anaerobic infection.
It is classically due to anaerobic infection and Fuso bacterium necrophorum is the most common pathogen (3).
Its pipeline includes three anti-infective programs: ATI-1501, a novel taste-masking technology applied in an oral suspension for the treatment for anaerobic infections, ATI-1503, a novel antibiotic targeting drug-resistant Gram-negative infections, and ATI-1701, a vaccine reducing the threat of tularemia bioterrorism.
Her research focuses on atypical pneumonia, vectorborne diseases, anaerobic infections, probiotics, and metagenomics.